From: Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
OS
HR (95% CI)
P
Platinum sensitive
No
Ref.
Yes
0.59 (0.32–1.11)
0.102
Prior lines of chemotherapy
1–3
4–5
3.82 (1.68–8.72)
0.001
Performance status
0–1
2
2.93 (1.63–5.28)
< 0.001
NLR
Low
High
2.17 (1.21–3.88)
0.009